HOME >> BIOLOGY >> NEWS
Molecules in blood foretell development of preeclampsia

High levels of two proteins in the blood of pregnant women appear to indicate the subsequent development of preeclampsia, a life-threatening complication of pregnancy, report a team of researchers from the National Institutes of Health and Beth Israel Deaconess Medical Center. The proteins, which interfere with the growth and function of blood vessels, also signal the development of high blood pressure during pregnancy.

The findings appear in the September 7 New England Journal of Medicine.

"This finding appears to be an important step in developing a cure for preeclampsia," said Elias A. Zerhouni, M.D., Director of the National Institutes of Health. "It may also provide the basis for predicting whether or not a woman will develop the disorder."

Preeclampsia is a leading cause of maternal death and often occurs without warning. The condition results in high blood pressure and protein in the urine. Preeclampsia may begin with mild symptoms, then progress to severe preeclampsia and to eclampsia--dangerously high blood pressure and convulsions--which may result in disability or death. When preeclampsia is not severe, the high blood pressure it causes can usually be treated in the short term. The only cure for preeclampsia is delivery of the baby. The condition is estimated to complicate from 3 to 5 percent of all pregnancies.

When preeclampsia occurs late in a pregnancy, the baby can be delivered with relatively few ill effects. However, if preeclampsia occurs early in pregnancy, delivery of the baby would result in premature birth, which increases the risk of death, and for such lifelong complications as blindness, cerebral palsy, and learning disabilities. In such instances, physicians are forced to weigh the mother's risk of severe disease or eclampsia against the consequences of preterm birth for the baby.

In the current study, the researchers present strong evidence that an imbalance of two proteins
'"/>

Contact: Robert Bock
bockr@mail.nih.gov
301-496-5133
NIH/National Institute of Child Health and Human Development
6-Sep-2006


Page: 1 2 3 4

Related biology news :

1. High blood pressure, low energy -- a recipe for heart failure
2. Brain blood flow gives clues to treating depression
3. Study finds gender differences in renal and other genes contributing to blood pressure
4. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
5. Research aims to identify markers for menopausal women at risk for deadly blood clot
6. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
7. A low expression of MX2 gene exists in the white blood cells of narcoleptics
8. How a pain in the neck could be bad for your blood pressure
9. Penn researchers discover pathway that eliminates genetic defects in red blood cells
10. U-M team identifies gene that regulates blood-forming fetal stem cells
11. MicroRNA works with Ago2 protein to regulate blood cell development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... January 24, 2020 , ... The Rockies ... capital resources to support early-stage bioscience companies in the state. , ... to find the funding they need to innovate and grow. This program ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... red blood cells from stem cells. The red blood cells are made ... strictly controlled conditions, for transfusion therapy and replaces the need for a human ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, ... a consortium of over 100 partner organizations from industry, government, academia and ...
Breaking Biology News(10 mins):
(Date:12/31/2019)... ... December 31, 2019 , ... Vici Health ... development lab in Maryland. Emphasis will be in expanding capabilities in both ... Health Sciences will be well positioned to meet the growing demand for its ...
(Date:12/27/2019)... ... December 27, 2019 , ... Vici Health Sciences is announcing ... that offers patients and healthcare providers options in the treatment of chronic ... with doctors and managed care professionals and developed at Vici’s R&D facility ...
(Date:12/18/2019)... ... , ... Tune in to CNBC on Saturday, December 28th at 11:00aET to ... more information on this program. , With a look at Avatar Partners , ... to increase the efficiency, safety and effectiveness of equipment, systems, and processes for the ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... and services, today announced a partnership with the Recombinant Antibody Network (RAN), a ... and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies ...
Breaking Biology Technology:
Cached News: